Yayın:
Everolimus-induced lymphedema in a renal transplant recipient: A case report

Küçük Resim

Tarih

Akademik Birimler

Kurum Yazarları

Ersoy, Alparslan
Koca, Nizameddin

Yazarlar

Danışman

Dil

Türü

Yayıncı:

Başkent Üniversitesi

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Özet

The mammalian target of rapamycin inhibitors is commonly preferred for solid organs for transplantation. Although these drugs have various adverse effects, sirolimus-related lymphedema has been rarely reported. We report a case of lymphedema related to everolimus after a kidney transplant. A 60-year-old woman successfully received a deceased-donor kidney. Everolimus was added to the treatment in postoperative month 3 owing to other immunosuppressive drugs' adverse effects. Edema occurred first on her feet in the first year after the transplant. During 3 months' follow-up, with no immunosuppressive adjustment, the edema progressed. Diagnosis of lymphedema was established. Several weeks after discontinuing everolimus, the patient's lymphedema began to resolve itself and completely disappeared in 3 months. The mammalian target of rapamycin inhibitors rarely causes lymphedema by inhibiting different subtypes of vascular endothelial growth factors, which results in impaired lymphangiogenesis. While there are few reports about sirolimus-related lymphedema, this case represents the first everolimus-related case of lymphedema. Further studies are warranted to explain the underlying mechanisms.

Açıklama

Kaynak:

Anahtar Kelimeler:

Konusu

Transplantation, Edema, Immunosuppression, Kidney transplant, Mtor inhibitors, Complication, Sirolimus, Lymphangiogenesis, Inhibition, Therapy, Vegf

Alıntı

Ersoy, A. ve Koca, N. (2012). "Everolimus-induced lymphedema in a renal transplant recipient: a case report". Experimental and Clinical Transplantation, 10(3), 296-298.

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads